Keymed Biosciences Co.ltd
Clinical trials sponsored by Keymed Biosciences Co.ltd, explained in plain language.
-
New drug trial targets common kidney disease
Disease control Not yet recruitingThis study is testing an experimental injection called CM313 for people with IgA nephropathy, a kidney disease. Researchers want to see if the drug is safe and effective at controlling the disease. The trial will enroll about 106 adults who have already been on standard blood pre…
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New injection tested for people with uncontrolled chronic hives
Disease control Not yet recruitingThis study is testing an investigational injection called CM512 to see if it can reduce the severity of hives and itching in adults with chronic spontaneous urticaria (CSU) who still have symptoms despite taking standard allergy medications. About 48 participants will be randomly…
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope for Tough-to-Treat blood cancer: experimental drug enters final testing phase
Disease control Not yet recruitingThis study aims to see if a new drug called CM336 works better than current standard treatments for people with multiple myeloma that has returned or stopped responding to previous therapies. It will involve about 280 adults whose cancer has progressed after at least two prior tr…
Phase: PHASE3 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC